MSI Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.61M Buy
140,163
+1,542
+1% +$73.2K 0.21% 113
2016
Q3
$6.91M Buy
138,621
+15,003
+12% +$761K 0.24% 99
2016
Q2
$5.95M Buy
123,618
+15,315
+14% +$729K 0.21% 113
2016
Q1
$4.95M Sell
108,303
-7,953
-7% -$372K 0.21% 112
2015
Q4
$6.27M Buy
116,256
+2,490
+2% +$131K 0.28% 87
2015
Q3
$5.61M Buy
113,766
+31,962
+39% +$1.83M 0.44% 43
2015
Q2
$4.77M Buy
81,804
+38,505
+89% +$2.25M 0.34% 63
2015
Q1
$2.49M Buy
43,299
+38,730
+848% +$2.12M 0.17% 134
2014
Q4
$231K Buy
4,569
+462
+11% +$22.5K 0.03% 547
2014
Q3
$192K Buy
4,107
+1,470
+56% +$66.4K 0.02% 595
2014
Q2
$119K Buy
2,637
+531
+25% +$22.8K 0.02% 745
2014
Q1
$89K Buy
2,106
+42
+2% +$1.76K 0.01% 794
2013
Q4
$81K Buy
2,064
+768
+59% +$28.8K 0.01% 823
2013
Q3
$46K Buy
1,296
+300
+30% +$10.6K 0.01% 900
2013
Q2
$33K Buy
+996
New +$33.1K 0.01% 1045

Other funds holding IHE

MSI Financial Services's IHE Position: Q4 2016 in Review

MSI Financial Services increased its iShares US Pharmaceuticals ETF (IHE) stake by 1.1% in Q4 2016, buying an estimated $73.2K and bringing the position to 140,163 shares worth $6.61M. The position accounts for 0.21% of the portfolio, ranked #113.

MSI Financial Services first reported a position in IHE in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.91M in Q3 2016. 92 funds tracked by Wall St. Rank hold IHE as of Q4 2016.

  • MSI Financial Services held 140,163 shares of iShares US Pharmaceuticals ETF worth $6.61M as of Q4 2016.
  • MSI Financial Services bought 1,542 iShares US Pharmaceuticals ETF shares in Q4 2016, an estimated $73.2K.
  • iShares US Pharmaceuticals ETF made up 0.21% of MSI Financial Services's portfolio in Q4 2016, its #113 holding.
  • MSI Financial Services first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's iShares US Pharmaceuticals ETF position peaked at $6.91M in Q3 2016.
  • 92 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.